Profile
Geoffrey E.
Clark is currently the Chairman at Ischemix, Inc. He was formerly the Chief Medical Officer at Citius Pharmaceuticals, Inc.
Geoffrey E. Clark active positions
| Companies | Position | Start |
|---|---|---|
Ischemix, Inc.
 Ischemix, Inc. Pharmaceuticals: MajorHealth Technology Ischemix, Inc. is a privately-held drug development company based in an undisclosed location. The American company focuses on developing its family of cytoprotective compounds for serious diseases and conditions, with the primary focus being the development of its lead compound, CMX-2043, for the treatment of TBI. Ischemix is working to advance cytoprotective therapies. The company was founded in 1999 by Victor Shashoua, and David DeWahl has been the CEO of the company since 2013. | Chairman | - |
Former positions of Geoffrey E. Clark
| Companies | Position | End |
|---|---|---|
| CITIUS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 12/09/2014 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CITIUS PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Ischemix, Inc.
Ischemix, Inc. Pharmaceuticals: MajorHealth Technology Ischemix, Inc. is a privately-held drug development company based in an undisclosed location. The American company focuses on developing its family of cytoprotective compounds for serious diseases and conditions, with the primary focus being the development of its lead compound, CMX-2043, for the treatment of TBI. Ischemix is working to advance cytoprotective therapies. The company was founded in 1999 by Victor Shashoua, and David DeWahl has been the CEO of the company since 2013. | Health Technology |
- Stock Market
- Insiders
- Geoffrey E. Clark
